Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dry powder mannitol adjunctive therapy for cystic fibrosis pulmonary exacerbation during hospitalization
ACTRN12612001167853Phase 2Recruiting
- Sponsor
- The Children's Hospital at Westmead
- Start
- Nov 2007
- Modality
- Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2 trial of Bronchitol in cystic fibrosis (CF) (2 arms), sponsored by The Children's Hospital at Westmead. Primary endpoint: Improvement in clinical status. Started Nov 2007; status: recruiting.
02
Drugs
Bronchitol
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on ACTRN12612001167853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612001167853.